Skip to the page content
Your donations
Passes our checks

Socal Association for Biomedical and Pharmaceutical Advancements

EIN 73-1627787 · San Diego, CA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong100 out of 100GovernanceStrong91 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

SABPA'S PRIMARY MISSION AND MOST SIGNIFICANT ACTIVITIES ARE TO PROMOTE SCIENCE AND INNOVATION. (1). TO PROVIDE FORUMS FOR FACILITATING INTERACTION AND COMMUNCATIONS AMONG BIOTECHINAL PROESSIONALSIONALS IN GLBOAL SCIENCE AND TECHNOLOGY ARENA;(2). TO PROMOTE INTERACTION AND COLLABORATION IN SCIENCE AND TECHNOLOGY ACROSS THE PACIFIC REGIONS; AND(3). TO STIMULATE AND NURTURE THE INNOVATIVE IDEAS, CUTTING-EDGE TECHNOLOGIES, ENTREPRENEURSHIP AND BRINGING PUBLIC AWARENESS OF THE BENEFITS OF BIOMEDICAL RESEARCH.

Income
$262,586
Spending
$227,141
Spent on programs
96%
Reserves
22.2 months of spending
Largest source of income
fees for its services, 78%
Employees
0
Volunteers
30

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 100 out of 100. Higher than 83% of charities in its peer group (science, $250k to $1m).

  • Reserves

    35 of 35

    Spendable reserves would cover 22.2 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 13% of income.

  • Income trend

    15 of 15

    Income rose 41% on the year before.

  • Spending floor

    15 of 15

    96% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 91 out of 100. Higher than 82% of charities in its peer group (science, $250k to $1m).

  • Independent board

    25 of 25

    22 of 22 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $127,897 spent. The 20th San Diego SABPA BioPharma Conference (October 5, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CAFor the past 20 years, San Diego BioPharma Conference, the flagship event of SABPA, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation's premier innovation centers. From potential Nobel laureates and technologically disruptive inventors to entrepreneurs and multi-billion-dollar dealmakers, this annual conference has been featuring some of the most respectful figures in the fields. This year, the long-awaited in-person conference is back.Program highlights are as follows:1. Fireside Chats on Taking a Research Organization towards Commercialization2. Breakthrough Prize Winner achievements in Serial Innovation in Drug Development3. The journey From Academia to Industry in Neuroscience IPOs4. Discovering the transformative impact of Moores Cancer Center's New Director, a world-renowned Pancreatic SurgeonDelving into cutting-edge innovations like Next-Gen Chemo proteomics Platforms
  2. $72,008 spent. The 8th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum (March 23, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CASABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform for local biotech companies to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference was set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: Glucagon-like peptide-1 (GLP-1), Antibody-Drug Conjugates (ADC), and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics. Program highlights are as follows:1. GLP-1 receptor agonists, from diabetes to obesity and beyond2. The rise of ADC - a biological missile, for targeted cancer therapy3. Reinventing drug discovery with AI-powered automation4. Frontiers in MRD detection to increase chance of cancer cure
  3. $18,994 spent. SABPA OC/LA 16th Annual Biomedical Forum (April 20, 2024)Address: The Beckman Center, 100 Academy, Irvine, CA, 92617SABPA OC/LA annually brings together the latest innovations in biomedical industries, cutting-edge developments of pharmaceuticals and medical devices, entrepreneurship, and career development. The event's broad spectrum of topics provides a platform for local biotech and medical device companies to engage in vibrant discussions and valuable networking opportunities.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 2002.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.